Payer Medical Policies Can Promote Effective Use of Comprehensive Sequencing In Community Oncology Setting
...
...
From - Laboratory Industry Report
The Theranos debacle hasn't dissuaded retailers from partnering with labs…
From - Diagnostic Testing & Emerging Technologies
Blood-based cytokine markers may help identify cancer patients at greatest risk of developing side effects from immunotherapy treatment, according to…
From - Diagnostic Testing & Emerging Technologies
The majority of U.S. oncologists report using next-generation sequencing-based (NGS-based) tests to guide patient care, according to a study published…
...